Follow the XOMA Royalty Corp stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). The latest transaction was filed on 16 July 2026 (U). Among the most active insiders: Sitko Bradley. Every trade is accessible without an account.
72
Insider Decl.
n/a
Thresholds
€3m
9 ops.
Buy Volume
€20m
16 ops.
Sell Volume
40Σ signal
Buys €3m€20m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
82 shares8.625% Series A Cumulative Perpetual Preferred StockSEC:0001193125-26-303722:7
25 of 72 declarations
About XOMA Royalty Corp
XOMA Royalty Corp is a company focused on managing royalties related to pharmaceutical products. It specializes in acquiring and managing royalty rights on innovative drugs.